BioPharma Resources

Company · GSK

GSK

Includes drugs filed under related and acquired sponsor names. Trials are searched under: GlaxoSmithKline; ViiV Healthcare; Tesaro, Inc..

Last checked: Nov 19, 2026Source: Drugs@FDA, ClinicalTrials.gov

NDAs and BLAs

148

57 still marketed

Novel approvals

49

Approvals since 2021

66

Originals and new uses

Phase 3 trials

949

Registered, any status

Trials by phase

All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.

Recent approvals

Originals and efficacy supplements, newest first.

  • Hibsago approved NovelPriority reviewOct 20, 2026
  • Jemperli new use Priority reviewOct 19, 2026
  • Tivicay new use Priority reviewAug 25, 2026
  • Tivicay Pd new use Priority reviewAug 25, 2026
  • Utebzi approved NovelPriority reviewJun 17, 2026
  • Wellcovorin new use Priority reviewMar 9, 2026
  • Exdensur approved NovelDec 16, 2025
  • Blujepa new use Priority reviewDec 11, 2025
  • Blenrep approved OrphanOct 23, 2025
  • Benlysta new use Jun 20, 2025

Drugs in development (61)

Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.

Open in pipeline
  • IvonescimabAK112, SMT112Phase 349 trials

    Akeso · Non-Small Cell Lung Cancer, Advanced Malignant Tumors, Advanced Solid Tumors

  • HS-20093Ris-Rez, Risvutatug rezetecanPhase 316 trials

    Hansoh BioMedical R&D Company · Neoplasms, Lung, Sarcoma, Osteosarcoma

  • GSK5784283Phase 38 trials

    GSK · Pulmonary Disease, Chronic Obstructive, Asthma, Nasal Polyps

  • PD-1 inhibitorPhase 38 trials

    BioAtla, Inc. · Advanced Solid Tumors, Gastric or Gastroesophageal Junction Adenocarcinoma, NSCLC (Advanced Non-small Cell Lung Cancer)

  • EfimosferminBOS-580Phase 37 trials

    GSK · Non-alcoholic Fatty Liver Disease, Metabolic Dysfunction-associated Steatohepatitis, Liver Diseases, Alcoholic

  • GlucocorticoidsPhase 37 trials

    Novartis · VEXAS Syndrome, ANCA Associated Vasculitis (AAV), Anti-Glomerular Basement Membrane Disease

  • Mocertatug rezetecanMo-RezPhase 36 trials

    GSK · Ovarian Neoplasms, Neoplasms, Endometrial, Tumours, Gynecological

  • rHuPH20Phase 35 trials

    Bristol Myers Squibb · Melanoma, Relapsing-remitting Multiple Sclerosis, Clear Cell Renal Cell Carcinoma

  • CamlipixantBLU-5937Phase 34 trials

    GSK · Refractory Chronic Cough, Cough, Irritable Bowel Syndrome

  • CAPEOXPhase 34 trials

    GSK · Neoplasms, Colon, Colonic Neoplasms, Colorectal Adenoma

  • DTap-HepB-IPV-Hib vaccineHexyon, Infanrix hexaPhase 34 trials

    Sanofi · Healthy Volunteers, Meningococcal Immunization, Pneumococcal Immunization

  • BelrestotugEOS884448, GSK4428859APhase 33 trials

    GSK · Lung Cancer, Non-Small Cell, Neoplasms, Head and Neck

  • GSK · Chickenpox

  • MMR vaccinePhase 33 trials

    GSK · Chickenpox

  • GSK · Respiratory Syncytial Virus Infections

  • VelzatinibGSK6042981Phase 33 trials

    GSK · Gastrointestinal Neoplasms, Gastrointestinal Stromal Neoplasms

  • 2 NRTIsPhase 32 trials

    Merck & Co. · Human Immunodeficiency Virus (HIV) Infection, Infection, Human Immunodeficiency Virus, HIV Infections

  • ABC3TC STR, 3TC immediate releasePhase 32 trials

    GSK · HIV Infections

  • ARTPhase 32 trials

    GSK · HIV Infections, HIV-1 Infection

  • CobolimabPhase 32 trials

    GSK · Melanoma, Hodgkin Lymphoma, High and Low Grade Glioma

  • DTGPhase 32 trials

    Jiangsu Aidea Pharmaceutical Group Co., Ltd. · Infection, Human Immunodeficiency Virus, HIV Infections

  • HFA-134aPhase 32 trials

    GSK · Asthma

  • HFA-152aPhase 32 trials

    GSK · Asthma

  • GSK · Chickenpox

  • RSVPreF3 OA vaccinePhase 32 trials

    GSK · Respiratory Syncytial Virus Infections

Recruiting Phase 3 trials

Largest first.

Marketed drugs (57)

Newest FDA action first.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.